Imbruvica is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pharmacyclics Llc. The primary component is Ibrutinib.
Product ID | 57962-420_0d02fa60-b63e-4a9d-9db2-0138cd052b33 |
NDC | 57962-420 |
Product Type | Human Prescription Drug |
Proprietary Name | Imbruvica |
Generic Name | Ibrutinib |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2018-02-16 |
Marketing Category | NDA / NDA |
Application Number | NDA210563 |
Labeler Name | Pharmacyclics LLC |
Substance Name | IBRUTINIB |
Active Ingredient Strength | 420 mg/1 |
Pharm Classes | Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2018-02-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA210563 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-02-06 |
Marketing Category | NDA |
Application Number | NDA210563 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-02-16 |
Ingredient | Strength |
---|---|
IBRUTINIB | 420 mg/1 |
SPL SET ID: | 0dfd0279-ff17-4ea9-89be-9803c71bab44 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
57962-007 | Imbruvica | Ibrutinib |
57962-014 | Imbruvica | Ibrutinib |
57962-070 | Imbruvica | Ibrutinib |
57962-140 | Imbruvica | Ibrutinib |
57962-280 | Imbruvica | Imbruvica |
57962-420 | Imbruvica | Imbruvica |
57962-560 | Imbruvica | Imbruvica |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
IMBRUVICA 86012748 not registered Dead/Abandoned |
Pharmacyclics, Inc. 2013-07-17 |
IMBRUVICA 86007097 4523481 Live/Registered |
Pharmacyclics, Inc. 2013-07-10 |